Stop Selecting Sites: Start Building a Strategy

About this session

Data-driven country and site selection is evolving from a tactical study-level activity into a strategic driver of global clinical development. As organizations face increasing pressure to deliver trials faster, smarter, and more efficiently, country and site decisions must balance immediate study needs with long-term portfolio objectives. Join us to explore how leading organizations are leveraging data, analytics, and enterprise thinking to optimize country and site selection through evidence-based decision making, align study placement with broader portfolio and network strategies, and strengthen site relationships through intentional partnerships.

Speaker

• 

  Erica Danielson

  Therapeutic Area Lead, Global Feasibility & Planning, Oncology · Boehringer Ingelheim Pharmaceuticals

  Speaker